Portfolio
Our investment portfolio includes these selected examples. Original underwriting dates shown, with dollar amounts rounded to nearest million.
Current Investments
Acer Therapeutics
03.07.22
$13.5 million
Structured Credit
Advanced Oxygen Therapy
03.21.22
$12.0 million
Structured Credit
Aziyo Biologics
08.10.22
$25.0 million
Structured Credit
Best ABT
11.12.18
$5.8 million
Royalty Reorganization
BIOLASE
11.09.18
$15.0 million
Structured Credit
Biotricity
12.27.21
$12.0 million
Structured Credit
Cambia
07.31.14
$9.5 million
Royalty Acquisition
Coflex
08.31.20
$4.4 million
Royalty Portfolio Acquisition
Secured Royalty Financing for Pharmaceutical Product
Women’s Health
06.07.13
$3.05 million
Royalty Financing
Exeevo
07.01.22
$7.5 million
Structured Credit
Epica International
07.25.18
$14.0 million
Structured Credit
Eton Pharmaceuticals
11.14.19
$10.0 million
Structured Credit
Flowonix Medical
12.23.20
$10.0 million
Structured Credit
ForFivo (IntelGenx)
08.05.16
$6.0 million
Royalty Acquisition
4WEB Medical
06.03.19
$20.0 million
Structured Credit
Ideal Implant
04.27.21
$5.0 million
Synthetic Royalty Financing
Iluvien
12.18.20
$16.5 million
Royalty Acquisition
Kybella
08.31.20
$4.4 million
Royalty Portfolio Acquisition
MedMinder Systems
08.18.22
$25.0 million
Structured Credit
MolecuLight
1.04.22
$10.0 million
Structured Credit
Sincerus Pharmaceuticals
3.19.21
$12.3 million
Structured Credit
Trio Healthcare
7.01.21
$9.5 million
Structured Credit
Veru
03.05.18
$12.0 million
Synthetic Royalty Financing
Secured Royalty Financing for Pharmaceutical Product
NovaQuest
06.07.13
$16.5 million
Royalty Acquisition
Legacy Investments
Narcan
11.07.16
$17.5 million
Royalty Acquisition
Tissue Regeneration Therapeutics
06.12.13
$3.3 million
Royalty Acquisition
Nautilus
12.05.12
$22.5 million
Structured Credit
InnoPran XL
05.14.13
$13.0 million
Acquisition & Sublicensing
Tribute
08.08.13
$14.0 million
Structured Credit
SynCardia
12.13.13
$10.0 million
Structured Credit & Synthetic Royalty Financing
Parnell #1
01.23.14
$25.0 million
Structured Credit
Response Genetics
07.30.14
$12.0 million
Structured Credit
ABT
10.10.14
$10.0 million
Structured Credit
PDI
10.13.14
$20.0 million
Structured Credit
Galil
12.10.14
$12.5 million
Structured Credit
Hooper Holmes
04.17.15
$5.0 million
Structured Credit
Nanosphere
05.14.15
$30.0 million
Structured Credit
Parnell #2
11.22.16
$20.0 million
Structured Credit
OraMetrix
12.15.16
$8.5 million
Structured Credit
Hooper Holmes / Provant
05.01.17
$8.5 million
Structured Credit
EyePoint Pharmaceuticals
03.28.18
$20.0 million
Structured Credit
Thermedx LLC
05.05.16
$3.5 million
Structured Credit
Solsys (f/k/a Soluble Systems)
10.26.17
$20.0 million
Structured Credit
Cheetah Medical
01.15.19
$20.0 million
Structured Credit
Aimmune Therapeutics
02.12.19
$5.0 million
Structured Credit
Tenex Health
07.01.16
$9.0 million
Structured Credit
Harrow Health
07.19.17
$21.0 million
Structured Credit
Misonix
9.27.19
$30.0 million
Structured Credit
DxTerity
04.06.15
$9.5 million
Structured Credit
CeloNova BioSciences
07.31.17
$25.0 million
Structured Credit
Thermedx
05.05.16
$0.4 million
Note Financing
Acerus Pharmaceuticals
10.11.18
$11.0 million
Structured Credit
B&D Dental
12.10.13
$6.5 million
Structured Credit
Keystone Dental
05.23.16
$20.0 million
Structured Credit
Beleodaq
06.06.18
$7.5 million
Royalty Acquisition
Besivance
04.02.13
$16.0 million
Royalty Acquisition
Trio Healthcare
10.22.20
$3.9 million
Royalty Acquisition
Zalviso
08.31.20
$4.4 million
Royalty Portfolio Acquisition